NEW YORK, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood ...
San Diego, California; London, UK and Bergisch Gladbach, Germany, December 18, 2023 – Replay, a genome writing company reprogramming biology by writing, designing and delivering big DNA, and Miltenyi ...
Miltenyi Biotec opens first office and Technology Center in Hyderabad, India, focusing on Cell and Gene Therapy (CGT). The Center offers training, research, and manufacturing solutions for CGT, using ...
This seminar will give attendees a full overview of two new Miltenyi cell sorting platforms, the MultiMACS X and the CliniMACS Prodigy and how these instruments can be used in various primary cell ...
IsoPlexis, which recently received an NCI grant, reports that it has published a technology note with Miltenyi Biotec in a co-marketing agreement. The tech note (“Getting the most out of your CAR-T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results